GTHX vs. XBI
Compare and contrast key facts about G1 Therapeutics, Inc. (GTHX) and SPDR S&P Biotech ETF (XBI).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GTHX or XBI.
Correlation
The correlation between GTHX and XBI is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
GTHX vs. XBI - Performance Comparison
Key characteristics
Returns By Period
GTHX
N/A
N/A
N/A
N/A
N/A
N/A
XBI
2.95%
2.44%
-7.39%
0.41%
-0.87%
2.79%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GTHX vs. XBI — Risk-Adjusted Performance Rank
GTHX
XBI
GTHX vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for G1 Therapeutics, Inc. (GTHX) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GTHX vs. XBI - Dividend Comparison
GTHX has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.14%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GTHX G1 Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.14% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
GTHX vs. XBI - Drawdown Comparison
Volatility
GTHX vs. XBI - Volatility Comparison
The current volatility for G1 Therapeutics, Inc. (GTHX) is 0.00%, while SPDR S&P Biotech ETF (XBI) has a volatility of 5.62%. This indicates that GTHX experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.